ARC1 Antibody

Shipped with Ice Packs
In Stock

Description

Table 1: Major ARC1 Antibodies and Their Properties

Product IDHost SpeciesClone TypeReactivityApplicationsMolecular Weight (Observed)
66550-1-Ig MouseMonoclonalHuman, Mouse, Rat, Pig, RabbitWB, IHC, IF/ICC, ELISA50 kDa
16290-1-AP RabbitPolyclonalHuman, Mouse, RatWB, IHC, IF, IP, ELISA45–50 kDa
#94147 RabbitPolyclonalHumanWB, IHC, IF, IP27 kDa (monomer)
#38916 RabbitMonoclonalHumanWB, IP, IHC, IF, Flow Cytometry27 kDa

Key Features:

  • Immunogen: Most antibodies (e.g., 66550-1-Ig, 16290-1-AP) use recombinant ARC fusion proteins for high specificity .

  • Cross-Reactivity: Mouse and rabbit antibodies show broad reactivity across mammals (human, mouse, rat) but not Drosophila Arc1 unless explicitly tested .

  • Storage: PBS with 0.02% sodium azide and 50% glycerol at -20°C ensures long-term stability .

Neuronal Plasticity and Memory

  • ARC1 regulates synaptic plasticity by modulating AMPA receptor trafficking and dendritic spine morphology . Antibodies like 16290-1-AP have been used to detect ARC1 in brain tissues, revealing its activity-dependent expression in dendritic spines .

  • In Drosophila, Arc1 (homologous to mammalian ARC) forms retrovirus-like capsids for mRNA transport between neurons and muscles, a process validated using immunostaining .

Metabolic Regulation

  • ARC1 antibodies (e.g., 66550-1-Ig) identified Arc1 as a fat storage regulator in Drosophila larvae. Null mutants showed increased body fat, while overexpression reduced lipid accumulation .

  • ARC1 interacts with microbiota to modulate growth and metabolism. Germ-free Drosophila lacking Arc1 exhibit stunted growth, reversible by Acetobacter colonization .

Disease Associations

  • ARC1 dysfunction is linked to autism, schizophrenia, and Alzheimer’s disease. Antibodies like #94147 detect ARC in human brain tissues, where it suppresses apoptosis and necroptosis in cancer cells .

Table 2: Antibody Validation in Key Studies

Study FocusAntibody UsedKey FindingsSource
Synaptic plasticity16290-1-AP Detected ARC monomers (~50 kDa) and dimers (~130 kDa) in rat neurons
Metabolic homeostasis66550-1-Ig Confirmed tissue-specific Arc1 expression changes in microbiota-depleted flies
Apoptosis regulation#94147 Identified ARC’s role in blocking Bax-mediated apoptosis in cancer cells

Species Specificity Considerations

  • Mammalian ARC antibodies (e.g., 66550-1-Ig) do not cross-react with Drosophila Arc1 due to sequence divergence. Studies on Drosophila require species-specific tools .

  • Human/mouse-reactive antibodies (e.g., #38916) are optimized for detecting post-translational modifications like Thr149 phosphorylation, critical for mitochondrial targeting .

Limitations and Alternatives

  • Multimer Detection: ARC forms oligomers (dimers, trimers) that may require crosslinking agents (e.g., DSG) for stabilization during WB .

  • Alternative Targets: For Drosophila Arc1, custom antibodies or RNAi are often necessary due to limited commercial options .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ARC1 antibody; G4P1 antibody; YGL105W antibody; G3085 antibody; tRNA-aminoacylation cofactor ARC1 antibody; Acyl-RNA-complex protein 1 antibody; GU4 nucleic-binding protein 1 antibody; G4p1 protein antibody; P42 antibody; tRNA-interacting factor ARC1 antibody
Target Names
ARC1
Uniprot No.

Target Background

Function
ARC1 antibody binds to tRNA and serves as a cofactor for the methionyl-tRNA synthetase (MetRS) and glutamyl-tRNA synthetase (GluRS). It forms a complex with MetRS and GluRS, enhancing their affinity for cognate tRNAs due to the presence of a tRNA binding domain within its middle and C-terminal regions. ARC1 antibody specifically binds to G4 quadruplex nucleic acid structures, which are four-stranded right-handed helices stabilized by guanine base quartets. Additionally, it is essential for the cytoplasmic confinement of the synthetases and tRNA.
Gene References Into Functions
  1. A study suggests that the structure and function of Arc1p can be modulated via biotinylation in response to temperature changes. PMID: 27330079
  2. An ab initio model of both trimeric and pentameric complexes containing Arc1, GluRS, and MetRS has been developed. PMID: 23161686
  3. Current research suggests a more complex mechanism for Arc1p-mediated stimulation of yeast tRNA glutamylation than simply increasing the glutamyl-tRNA synthetase binding affinity for tRNAGlu. PMID: 15667228
  4. The cytoplasmic localization of Arc1p is maintained through Xpo1p-dependent nuclear export. PMID: 15710377
  5. The dual localization of (c)ERS is regulated by its binding to Arc1p. PMID: 19417106

Show More

Hide All

Database Links

KEGG: sce:YGL105W

STRING: 4932.YGL105W

Protein Families
TRNA-aminoacylation cofactor ARC1 family
Subcellular Location
Cytoplasm. Note=Largely excluded from the nucleus.

Q&A

What is ARC1 and what are its primary functions in neural tissue?

ARC1 is a conserved activity-regulated immediate early gene product that plays crucial roles beyond memory and learning. Research has revealed that ARC1 is involved in neuronal regulation of organismal metabolism, particularly in fat storage regulation . Unlike other immediate early genes such as jra and kay (fly orthologs of jun and c-fos), ARC1 shows stronger induction in response to neuronal activity, suggesting more specific effector roles .

The protein functions in both pre- and postsynaptic compartments and has been observed in multivesicular body-like structures (MVBLS) and extracellular vesicles (EVs) in the synaptic cleft of glutamatergic synapses . Recent evidence also supports inter-neuronal in vivo transfer of Arc in the mammalian brain .

How is ARC1 expression distributed across different brain regions?

ARC1 shows distinct expression patterns across brain regions, with quantitative differences that can be visualized through western blotting and immunohistochemistry.

Brain RegionRelative Expression LevelNotes
CortexHighShows prominent immunoreactivity
HippocampusHighShows prominent immunoreactivity
CerebellumModerateCortex shows prominent staining but white matter shows weak staining
ThalamusLow to moderateLower band intensities compared to cortex and hippocampus
Brain StemLow to moderateLower band intensities compared to cortex and hippocampus

In Drosophila studies, ARC1 expression has been observed in specific clusters of cells that respond to neuronal activity, with differential expression patterns in the ventral nerve cord (VNC) and subesophageal ganglion (SOG) .

How can I verify the specificity of ARC1 antibodies?

Antibody specificity is critical for reliable research results. The polyclonal rabbit Arc antibody from Synaptic Systems (Cat#156003, RRID: AB_887694) has been verified for specificity through:

  • Immunocytochemistry of dissociated hippocampal neuron cultures prepared from wild type (WT) and Arc knockout (KO) littermates

  • Western blotting, which should show a single immunoreactive band at the expected molecular weight

For your own validation, consider these approaches:

  • Compare staining in wild-type tissues with Arc knockout tissues

  • Perform western blotting to confirm a single band at the appropriate molecular weight

  • Include appropriate negative controls in all experiments

  • Verify consistency of staining patterns with previously published results

What tissue preparation methods are optimal for ARC1 immunostaining?

For reliable ARC1 immunostaining in neural tissue, the following protocol has been successfully employed:

  • Dissect tissue (e.g., wandering 3rd instar larvae for Drosophila studies)

  • Fix with 4% paraformaldehyde overnight at 4°C

  • Wash three times with 0.1% PBTriton

  • Proceed with standard immunostaining protocols

For primary antibody dilution, researchers have successfully used:

  • 1:400 dilution for electron microscopy

  • 1:500 dilution for light microscopy

  • 1:600 dilution for western blot

How do activity-dependent changes in ARC1 expression correlate with functional outcomes?

ARC1 expression is dynamically regulated by neuronal activity, with specific functional consequences. In Drosophila studies, manipulation of E347 neuronal activity revealed that:

  • Stimulation of E347 neurons significantly increased ARC1-positive cells in the ventral nerve cord (VNC)

  • Silencing E347 neurons significantly decreased ARC1-positive cells in the VNC and subesophageal ganglion (SOG)

  • Interestingly, silencing E347 neurons increased ARC1-positive peripheral lobe cells

These region-specific changes in ARC1 expression correlate with metabolic regulation. Arc1 null mutants show increased body fat, decreased density consistent with increased fat storage, and significant metabolic alterations including:

  • Higher levels of glycogen breakdown products

  • Inefficient glucose oxidation through glycolysis and Krebs cycle

  • Accumulation of carbon backbone for de novo synthesis of triglycerides

  • ~330-fold reduction in transcripts encoding PEPCK

  • Highest statistically significant fold-change increase in aspartate

What experimental approaches can be used to visualize ARC1 protein dynamics in living neurons?

To visualize ARC1 dynamics in living neurons, researchers have successfully employed CRISPR/Cas9 homology-independent targeted integration (HITI) for knock-in of fluorescent markers. Key methodological considerations include:

  • Construction of an adeno-associated virus (AAV) system delivering:

    • Cas9

    • Reporter gene (mCherry or GFP)

    • Single guide RNA (sgRNA)

  • Targeting of genomic sites surrounding the start codon of the ARC open reading frame

  • Viral injection into target brain regions (e.g., striatum and hippocampus)

  • Visualization through immunohistochemistry and proximity ligation assay (PLA)

This approach allows production of a chimeric functional ARC protein in a sparse population of transduced neurons, facilitating in vivo synapse and cell-to-cell communication studies of ARC in the intact brain .

How can I differentiate between pre- and postsynaptic ARC1 localization?

Distinguishing between pre- and postsynaptic ARC1 localization requires high-resolution imaging techniques. Electron microscopy studies have revealed:

  • ARC-immunopositive multivesicular body-like structures (MVBLS)

  • ARC presence in both presynaptic and postsynaptic cytoplasm

  • ARC-immunopositive extracellular vesicles (EVs) in the synaptic cleft of glutamatergic synapses

For accurate differentiation, consider:

  • Using electron microscopy with immunogold labeling

  • Employing co-localization studies with established pre- and postsynaptic markers

  • Utilizing super-resolution microscopy techniques (STED, STORM, or PALM)

  • Combining with electrophysiological recordings to correlate localization with function

What are the methodological considerations for quantifying ARC1-positive cells in different brain regions?

Accurate quantification of ARC1-positive cells requires careful methodological approaches:

  • Perform immunostaining with validated antibodies (e.g., 1:500 dilution for light microscopy)

  • Collect images using a confocal microscope for optimal resolution

  • Conduct cell counts blind to experimental condition to prevent bias

  • Use appropriate statistical tests (e.g., Multiple t-test comparison for comparing cell counts between conditions)

When analyzing changes in ARC1 expression:

  • Count the number of clearly ARC1-positive cells in different regions of the brain under different conditions

  • Be aware that immunostaining may not be sensitive enough to detect changes in protein content per cell

  • Consider complementing cell counting with RT-qPCR or RNAseq for mRNA quantification

How can I investigate ARC1's role in inter-neuronal communication?

Recent evidence supports inter-neuronal transfer of ARC in the mammalian brain . To investigate this phenomenon:

  • Use CRISPR/Cas9 HITI to knock-in fluorescent markers (e.g., GFP or mCherry) to the ARC protein

  • This allows visualization of ARC protein dynamics in sparse populations of neurons

  • Examine the presence of labeled ARC in non-transduced neurons, which would indicate inter-neuronal transfer

  • Combine with electron microscopy to visualize ARC-containing extracellular vesicles in the synaptic cleft

For functional studies, consider:

  • Selectively manipulating ARC expression in specific neuronal populations

  • Examining the effects on neighboring cells' physiology and gene expression

  • Using microfluidic chambers to separate neuronal populations while allowing process interaction

What are the appropriate primer sequences for quantifying ARC1 mRNA expression?

For reliable quantification of ARC1 mRNA expression by RT-qPCR, researchers have successfully used the following primer pairs:

TargetPrimer PairSequence
Arc1Pair 1Forward: 5′ catcatcgagcacaacaacc 3′
Reverse: 5′ ctactcctcgtgctgctcct 3′
Arc1Pair 2Forward: 5′ tcggtctgctgaacatcaag 3′
Reverse: 5′ gtgttctttgctgtggcaag 3′

For normalization, consider housekeeping genes used in previous studies:

  • actin5c: Forward 5′ gagcgcggttactctttcac 3′, Reverse 5′ acttctccaacgaggagctg 3′

  • alpha-tubulin84B: Forward 5′ aacctgaaccgtctgattgg 3′, Reverse 5′ ggtcaccagagggaagtgaa 3′

When performing RT-qPCR:

  • Include at least three independent biological replicates

  • Use multiple comparisons ordinary one-way ANOVA to calculate statistical significance

  • Consider comparing ARC1 expression with other immediate early genes (e.g., jra and kay) to assess specificity of responses

Why might I observe variable ARC1 immunostaining results across experiments?

Variable immunostaining results can stem from several factors:

  • ARC1 expression is activity-dependent and can vary based on neuronal stimulation state

  • Expression patterns differ significantly across brain regions, with highest expression in cortex and hippocampus

  • Different fixation protocols may affect antibody accessibility to epitopes

  • ARC1 expression can change rapidly in response to experimental manipulations

To improve consistency:

  • Standardize tissue collection and preparation protocols

  • Control for time of day and animal activity levels before tissue collection

  • Ensure consistent fixation times and temperatures

  • Process all experimental groups in parallel

  • Include positive and negative controls in each experiment

How can I optimize experimental design to detect subtle changes in ARC1 expression?

Detecting subtle changes in ARC1 expression requires careful experimental design:

How might ARC1's metabolic regulatory functions inform therapeutic approaches?

ARC1's involvement in metabolic regulation presents intriguing therapeutic possibilities:

  • ARC1 null mutants show increased body fat and significant metabolic alterations, suggesting potential targets for obesity interventions

  • Key metabolic changes in ARC1 mutants include:

    • Inefficient glucose oxidation

    • Altered glycerol-phosphate generation

    • Increased activity of transaminases

    • Accumulation of branched-chain amino acids, phenylalanine, and tyrosine

Future research could explore:

  • Pharmacological modulation of ARC1 expression or function to influence metabolic outcomes

  • Cell-specific targeting of ARC1 in metabolically relevant neural circuits

  • Interaction between ARC1 and other metabolic regulators, such as insulin signaling pathways

  • Translational potential of ARC1-targeted approaches for metabolic disorders

What technological advances might improve our ability to study ARC1 dynamics?

Emerging technologies hold promise for advancing our understanding of ARC1 dynamics:

  • CRISPR/Cas9 HITI for fluorescent tagging of endogenous ARC1 enables visualization of the protein in living neurons

  • Super-resolution microscopy techniques could provide more detailed visualization of ARC1 localization at synapses

  • Optogenetic approaches combined with ARC1 visualization could help elucidate activity-dependent regulation

  • Single-cell transcriptomics could reveal cell-specific responses in ARC1 expression

Future technical developments might include:

  • Photoactivatable or photoconvertible ARC1 fusion proteins to track protein movement between cells

  • Genetically encoded indicators that report on ARC1 activity or interaction with binding partners

  • Cryo-electron microscopy to determine ARC1 structure and interaction with multivesicular bodies and extracellular vesicles

  • AI-assisted image analysis for high-throughput quantification of ARC1 dynamics across large datasets

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.